Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 1, 2022
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
[ Tue, Nov 01st 2022
] - WOPRAI
Mon, October 31, 2022
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
[ Mon, Oct 31st 2022
] - WOPRAI
Gary Nachman Maintained (ABBV) at Buy with Decreased Target to $169 on, Oct 31st, 2022
Gary Nachman of BMO Capital, Maintained "AbbVie Inc." (ABBV) at Buy with Decreased Target from $170 to $169 on, Oct 31st, 2022.
Gary has made no other calls on ABBV in the last 4 months.
There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 2 agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022
- Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $135 on, Friday, July 15th, 2022
These are the ratings of the 5 analyists that currently disagree with Gary
- David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
- Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022
